Active Filter(s):
Details:
Field Trip announced that FT-104 is a potent psychedelic molecule with rapid onset and a short duration. A 2mg/kg subcutaneous dose of FT104 to rats resulted in peak concentrations (Cmax) of the active agonist of 150+/-51 ng/ml at 60 min (Tmax) and bioavailability of 89%.
Lead Product(s): FT-104
Therapeutic Area: Psychiatry/Psychology Product Name: FT-104
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 29, 2020